ACAD
Price
$27.83
Change
+$0.09 (+0.32%)
Updated
Sep 11 closing price
Capitalization
4.8B
60 days until earnings call
Intraday BUY SELL Signals
RIGL
Price
$47.24
Change
-$0.04 (-0.08%)
Updated
Sep 11 closing price
Capitalization
882.16M
59 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACAD vs RIGL

ACAD vs RIGL Comparison Chart in %
View a ticker or compare two or three
VS
ACAD vs. RIGL commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACAD is a Hold and RIGL is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACAD($4.8B) has a higher market cap than RIGL($882M). ACAD has higher P/E ratio than RIGL: ACAD (12.48) vs RIGL (2.80). RIGL YTD gains are higher at: 10.297 vs. ACAD (4.193). ACAD (98.4M) and RIGL (94M) have comparable annual earnings (EBITDA) . ACAD has more cash in the bank: 956M vs. RIGL (95.3M). RIGL has less debt than ACAD: RIGL (40M) vs ACAD (73.9M). ACAD has higher revenues than RIGL: ACAD (1.14B) vs RIGL (277M).
ACADRIGLACAD / RIGL
Capitalization4.8B882M544%
EBITDA98.4M94M105%
Gain YTD4.19310.29741%
P/E Ratio12.482.80446%
Revenue1.14B277M411%
Total Cash956M95.3M1,003%
Total Debt73.9M40M185%
FUNDAMENTALS RATINGS
ACAD vs RIGL: Fundamental Ratings
ACAD
RIGL
OUTLOOK RATING
1..100
8969
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
45
Fair valued
PROFIT vs RISK RATING
1..100
6780
SMR RATING
1..100
2912
PRICE GROWTH RATING
1..100
4136
P/E GROWTH RATING
1..100
7997
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RIGL's Valuation (45) in the Biotechnology industry is in the same range as ACAD (69). This means that RIGL’s stock grew similarly to ACAD’s over the last 12 months.

ACAD's Profit vs Risk Rating (67) in the Biotechnology industry is in the same range as RIGL (80). This means that ACAD’s stock grew similarly to RIGL’s over the last 12 months.

RIGL's SMR Rating (12) in the Biotechnology industry is in the same range as ACAD (29). This means that RIGL’s stock grew similarly to ACAD’s over the last 12 months.

RIGL's Price Growth Rating (36) in the Biotechnology industry is in the same range as ACAD (41). This means that RIGL’s stock grew similarly to ACAD’s over the last 12 months.

ACAD's P/E Growth Rating (79) in the Biotechnology industry is in the same range as RIGL (97). This means that ACAD’s stock grew similarly to RIGL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACADRIGL
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
66%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 11 days ago
81%
Declines
ODDS (%)
Bearish Trend 12 days ago
67%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
82%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (ACAD: $27.83 vs. RIGL: $47.24)
Brand notoriety: ACAD and RIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACAD: 71% vs. RIGL: 84%
Market capitalization -- ACAD: $4.8B vs. RIGL: $882.16M
ACAD [@Biotechnology] is valued at $4.8B. RIGL’s [@Biotechnology] market capitalization is $882.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACAD’s FA Score shows that 1 FA rating(s) are green while RIGL’s FA Score has 1 green FA rating(s).

  • ACAD’s FA Score: 1 green, 4 red.
  • RIGL’s FA Score: 1 green, 4 red.
According to our system of comparison, RIGL is a better buy in the long-term than ACAD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACAD’s TA Score shows that 4 TA indicator(s) are bullish while RIGL’s TA Score has 2 bullish TA indicator(s).

  • ACAD’s TA Score: 4 bullish, 4 bearish.
  • RIGL’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, ACAD is a better buy in the short-term than RIGL.

Price Growth

ACAD (@Biotechnology) experienced а -0.68% price change this week, while RIGL (@Biotechnology) price change was -2.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

ACAD is expected to report earnings on Nov 11, 2026.

RIGL is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ACAD
Daily Signal:
Gain/Loss:
RIGL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PAVE54.080.72
+1.35%
Global X US Infrastructure Dev ETF
ROBT57.380.62
+1.10%
FT Nasdaq Artfcl Intllgnc and Rbtc ETF
RYLG24.09N/A
N/A
Global X Russell 2000 Cov Cl & Gr ETF
CPLS34.04-0.04
-0.12%
AB Core Plus Bond ETF
HRTS36.03-0.14
-0.39%
Tema Heart & Health ETF

ACAD and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACAD has been loosely correlated with CLDX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ACAD jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACAD
1D Price
Change %
ACAD100%
+0.32%
CLDX - ACAD
43%
Loosely correlated
-3.15%
RIGL - ACAD
43%
Loosely correlated
-0.08%
KRYS - ACAD
42%
Loosely correlated
+0.42%
SANA - ACAD
42%
Loosely correlated
+1.29%
DNLI - ACAD
41%
Loosely correlated
-1.45%
More

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been loosely correlated with ACAD. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if RIGL jumps, then ACAD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
-0.08%
ACAD - RIGL
43%
Loosely correlated
+0.32%
RPRX - RIGL
38%
Loosely correlated
-0.24%
SRPT - RIGL
35%
Loosely correlated
-0.34%
INCY - RIGL
34%
Loosely correlated
-1.47%
AKBA - RIGL
33%
Loosely correlated
+0.55%
More